Curium Near $7 Billion Acquisition of Lantheus
Curium is in advanced negotiations to acquire Lantheus Holdings Inc., a radiopharmaceutical company, in a deal valued at approximately $7 billion. The acquisition is expected to be announced within the coming days, according to sources familiar with the transaction. This deal represents a significant consolidation in the radiopharmaceutical sector.
Readers say
How does this story lean?
Outlet ratings above are Trace's curated source map. Vote here (same as on the home feed) — one vote per browser, changeable anytime. Rate individual outlets in the coverage list below.
Comments
0No comments yet. Say what you noticed in the coverage.
Trending